Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-10-31
2006-10-31
Berch, Mark L. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C544S254000, C544S323000
Reexamination Certificate
active
07129244
ABSTRACT:
A compound represented by Formula I, or a polymorph, ester, tautomer, enantiomer, diastereomer, pharmaceutically acceptable salt or prodrug thereof,Wherein R1is halogen, —OR11, —SR11or lower alkyl; R2is —NHR8; R4is —CHR12—, —C(O)—, —C(S)—, —S(O)— or —S2—; and R5is aryl, heteroaryl, alicyclic, or heterocyclic, wherein the aryl group is substituted with 4 to 5 substituents, the heteroaryl group is substituted with 3 to 5 substituents, the alicyclic group is substituted with 3 to 5 substituents, and the heterocyclic group is substituted with 3 to 5 substituents.
REFERENCES:
patent: 4495190 (1985-01-01), Hagberg et al.
patent: 4547573 (1985-10-01), Jung et al.
patent: 4617304 (1986-10-01), Ashton et al.
patent: 4699877 (1987-10-01), Cline et al.
patent: 4748177 (1988-05-01), Sircar et al.
patent: 4772606 (1988-09-01), Sircar et al.
patent: 4774325 (1988-09-01), Casadio et al.
patent: 4806642 (1989-02-01), Sircar et al.
patent: 4918162 (1990-04-01), Slamon et al.
patent: 4921859 (1990-05-01), Sircar et al.
patent: 4923885 (1990-05-01), Hupe et al.
patent: 4968603 (1990-11-01), Slamon et al.
patent: 5002950 (1991-03-01), Malone et al.
patent: 5098906 (1992-03-01), Sircar et al.
patent: 5110818 (1992-05-01), Allgeier
patent: 5204353 (1993-04-01), Meier et al.
patent: 5217866 (1993-06-01), Summerton et al.
patent: 5602156 (1997-02-01), Kohn et al.
patent: 5656629 (1997-08-01), Bacon et al.
patent: 5789394 (1998-08-01), Nguyen-Ba et al.
patent: 5846749 (1998-12-01), Slamon et al.
patent: 5861503 (1999-01-01), Barrio et al.
patent: 5917042 (1999-06-01), Daluge et al.
patent: 5955610 (1999-09-01), Nguyen-Ba et al.
patent: 6005107 (1999-12-01), Nguyen-Ba et al.
patent: 6174875 (2001-01-01), Defranco et al.
patent: 6210974 (2001-04-01), Gold et al.
patent: 6262254 (2001-07-01), Barrio et al.
patent: 6369092 (2002-04-01), Pamukcu et al.
patent: 6444656 (2002-09-01), Nguyen-Ba et al.
patent: 2002/0156277 (2002-10-01), Fick et al.
patent: 2002/0161014 (2002-10-01), Sadhu et al.
patent: 2003/0022864 (2003-01-01), Osjaq et al.
patent: 2003/0078413 (2003-04-01), Dempcy
patent: 2004/0097526 (2004-05-01), Gillespie et al.
patent: 2004/0102458 (2004-05-01), Chiosis et al.
patent: 2005/0043239 (2005-02-01), Douangpanya et al.
patent: 2005/0049263 (2005-03-01), Kasibhatla et al.
patent: 2005/0107343 (2005-05-01), Kasibhatla et al.
patent: 2005/0113340 (2005-05-01), Kasibhatla et al.
patent: 2005/0119282 (2005-06-01), Kasibhatla et al.
patent: 2006/0035909 (2006-02-01), Fuksova et al.
patent: 55239 (1982-06-01), None
patent: 151528 (1985-08-01), None
patent: 156559 (1985-10-01), None
patent: 159264 (1985-10-01), None
patent: 0178178 (1986-04-01), None
patent: 178178 (1986-04-01), None
patent: 0184322 (1986-06-01), None
patent: 206415 (1986-12-01), None
patent: 363320 (1990-04-01), None
patent: 0151528 (1990-07-01), None
patent: 465297 (1992-01-01), None
patent: 502690 (1992-09-01), None
patent: 565377 (1993-10-01), None
patent: 675123 (1995-10-01), None
patent: 10025294 (1988-01-01), None
patent: 06080670 (1994-03-01), None
patent: 08041035 (1996-02-01), None
patent: 08208687 (1996-08-01), None
patent: 09020776 (1997-01-01), None
patent: 09169758 2 (1997-06-01), None
patent: 2000-072773 (2000-03-01), None
patent: 2003-113181 (2003-04-01), None
patent: WO-1986-05518 (1986-09-01), None
patent: WO-1995-07695 (1995-03-01), None
patent: WO-1995-08327 (1995-03-01), None
patent: WO-1998-01448 (1998-01-01), None
patent: WO 98/51702 (1998-11-01), None
patent: WO-1999-01454 (1999-01-01), None
patent: WO-1999-02162 (1999-01-01), None
patent: WO-1999-12927 (1999-03-01), None
patent: WO-1999-24432 (1999-05-01), None
patent: WO-1999-32122 (1999-07-01), None
patent: WO 99/51223 (1999-10-01), None
patent: WO 00/06523 (2000-02-01), None
patent: WO-2000-043394 (2000-07-01), None
patent: WO-2000-044750 (2000-08-01), None
patent: WO-2000-068230 (2000-11-01), None
patent: WO-2001-38584 (2001-05-01), None
patent: WO-2001-049688 (2001-07-01), None
patent: WO 01/72779 (2001-10-01), None
patent: WO-2002-085905 (2001-10-01), None
patent: WO-2001-081346 (2001-11-01), None
patent: WO 02/02123 (2002-01-01), None
patent: WO 02/09696 (2002-02-01), None
patent: WO 02/36075 (2002-05-01), None
patent: WO 02/36171 (2002-05-01), None
patent: WO 02/055082 (2002-07-01), None
patent: WO 02/055083 (2002-07-01), None
patent: WO 02/055521 (2002-07-01), None
patent: WO-2002-055521 (2002-07-01), None
patent: WO-2002-057288 (2002-07-01), None
patent: WO 02/069900 (2002-09-01), None
patent: WO 02/094196 (2002-11-01), None
patent: WO-2002-088079 (2002-11-01), None
patent: WO-2002-088080 (2002-11-01), None
patent: WO-2002-102314 (2002-12-01), None
patent: WO-2003-000200 (2003-01-01), None
patent: WO-2003-002565 (2003-01-01), None
patent: WO 03/026591 (2003-04-01), None
patent: WO 03/037860 (2003-05-01), None
patent: WO 03/041643 (2003-05-01), None
patent: WO-2003-035938 (2003-05-01), None
patent: WO 03/050295 (2003-06-01), None
patent: WO 03/066005 (2003-08-01), None
patent: WO-2003-106458 (2003-12-01), None
patent: WO-2004-014913 (2004-02-01), None
patent: WO-2004-024082 (2004-03-01), None
patent: WO-2004-029064 (2004-04-01), None
patent: WO-2005-012324 (2005-02-01), None
patent: WO-2005-016348 (2005-02-01), None
patent: WO-2005-016349 (2005-02-01), None
patent: WO-2005-028434 (2005-03-01), None
U.S. Appl. No. 60/128,593, Rosen et al.
U.S. Appl. No. 60/293,246, Rosen et al.
U.S. Appl. No. 60/331,893, Zhang et al.
U.S. Appl. No. 60/335,391, Kasibhatla et al.
U.S. Appl. No. 60/337,919, Kasibhatla et al.
U.S. Appl. No. 60/340,762, Kamal et al.
U.S. Appl. No. 60/359,484, Nicchitta et al.
U.S. Appl. No. 60/371,668, Ulm et al.
Abblard, J. et al. “Preparation et determination de structure de nouvelles pyridines halogenees Mecanisme de l'halagenation” Bull. Soc. Chim. Fr. 1972, 2466.
Alhede, J. “A Simple and Efficient Synthesis of 9-Substituted Guanines. Cyclodesulfurization of 1-Substituted 5-[(Thiocarbamoyl)amino]imidazole-4-carboxamides under Aqueous Basic Conditions” Org. Chem., 1991, 2139.
Bennett, S. M., “Synthesis and Antiviral Activity of Some Acyclic and C-Acyclic Pyrrolo[2,3-d]pyrimidine Nucleoside Analogus” J. Med. 1990, 33, 2162.
Berge et al. “Pharmaceutical Salts”, J. Pharm. Sci. 1977, 66:1-19.
Blanz, E. J., et al. “Carcinostatic Activity of Thiosemicarbazones of Formyl Heteroaromatic Compounds. VII. 2-Formylpyridine Derivatives Bearing Additional Ring Sustituents” J. Med. Chem. 1970, 13, 1124.
Buchner, J., “Hsp90 & Co.-a holding for folding,” TIBS, Apr. 1999, 24:136-141.
Buchwald, Henry et al. “Long-term, continuous intravenous heparin administration by an implantable infusion pump in ambulatory patients with recurrent venous thrombosis” Surgery, 1980 88, 507.
Bundgaard, H. “Design and Application of Prodrugs” in A Textbook of Drug Design and Development, Krosgaard-Larsen and H. Bundgaard, Ed., 1991, Chapter 5, p. 113-191.
Bundgaard, H., Advanced Drug Delivery Review, 1992, 8, 1-38.
Caplan A., “Hsp90's secrets unfold: new insights from structural and functional studies,” Trends in Cell Biol., 1999, 9:262-268.
Chem, J.W. et al. “Certain 8-Amino-9-(benzyl)guanines as potential purine nucleoside phosphorylase inhibitors” Eur. J. Med. Chem. 1994, 29(1), 3-9.
Chiosis et al., “A Small Molecule Designed to Bind to the Adenine Nucleotide Picket of HSP90 Causes HER2 Degradation and the Growth Arrest and Differentiation of Breast Cancer Cells,” Chemistry & Biology, 8, pp. 289-299 (2001).
Chowdhury, Shafinaz F. et al. “Design, Synthesis, and Evaluation of Inhibitors of Trypanosomal and Leishmanial Dihtdrofolate Reductase” J. Med. Chem. 1999, 42, 4300.
Cory, A. et al. “Use of an aqueous soluble tetrazolium/formazan assay for cell growth assays in culture,” Cancer Commun. 1991, 3, 207-212.
Dai et al., “Physical interaction of mammalian CDC37 with CDK4,” J. Biol.
Boehm Marcus F.
Hong Kevin D.
Kasibhatla Srinivas Rao
Berch Mark L.
Conforma Therapeutics Corporation
Wilson Sonsini Goodrich & Rosati
LandOfFree
Triazolopyrimidines and related analogs as HSP90-inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Triazolopyrimidines and related analogs as HSP90-inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Triazolopyrimidines and related analogs as HSP90-inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3694245